Text Size

Levobupivacaine During Cholecystectomy

This study has been completed.
Sponsor:
Information provided by:
Ege University
ClinicalTrials.gov Identifier:
NCT00836316
First received: February 3, 2009
Last updated: NA
Last verified: February 2009
History: No changes posted
  Purpose

The purpose of this study is to determine the effects of intraperitoneal administration of levobupivacaine on pain after laparoscopic cholecystectomy.


Condition Intervention Phase
Cholelithiasis
Pain
 Drug: levobupivacaine
 Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: Effects of Intraperitoneal Levobupivacaine on Pain After Laparoscopic Cholecystectomy: A Prospective, Randomized, Double-Blinded Study

Resource links provided by NLM:

MedlinePlus related topics: Gallstones
U.S. FDA Resources

Further study details as provided by Ege University:

Enrollment: 40
Intervention Details:
    Drug: levobupivacaine
    intraperitoneal administration of levobupivacaine on pain after laparoscopic cholecystectomy
  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • cholelithiasis
  • chronic cholecystitis

Exclusion Criteria:

  • hypersensitivity to local anesthetics
  • acute cholecystitis
  • morbid obesity
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00836316

Locations
Turkey
Ege University School of Medicine
Izmir, Turkey, 35100
Sponsors and Collaborators
Ege University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00836316     History of Changes
Other Study ID Numbers: LDC-2008
Study First Received: February 3, 2009
Last Updated: February 3, 2009
Health Authority: Turkey: Ministry of Health

Keywords provided by Ege University:
laparoscopic cholecystectomy

Additional relevant MeSH terms:
Cholelithiasis
Cholecystolithiasis
Gallstones
Biliary Tract Diseases
Digestive System Diseases
Gallbladder Diseases
Calculi
Pathological Conditions, Anatomical
Levobupivacaine
Bupivacaine
 Anesthetics, Local
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs
Pharmacologic Actions
Sensory System Agents
Peripheral Nervous System Agents
Central Nervous System Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on May 23, 2013